Peter Libby Selected Research

Atherosclerosis (Atheroma)

02/2008	Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
11/2007	A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages.
09/2007	Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.
06/2007	Mast cells promote atherosclerosis by releasing proinflammatory cytokines.
05/2007	Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.
04/2007	Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.
04/2007	Atherosclerosis: the path from genomics to therapeutics.
01/2007	Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
10/2006	Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.
04/2006	C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
02/2006	Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells.
10/2005	Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study.
07/2005	Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment.
06/2005	Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells.
08/2004	Lysosomal cysteine proteases in atherosclerosis.
06/2004	Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
04/2004	B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
03/2004	Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.
03/2003	Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.
01/2003	Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI.
10/2002	Cytokines in the pathogenesis of atherosclerosis.
09/2002	Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice.
09/2002	Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol.
07/2002	Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.
04/2002	PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis.
01/2002	Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.

Articles by Research Topic

Disease

26	Atherosclerosis (Atheroma) 02/2008 - 01/2002
7	Inflammation 08/2008 - 09/2002
4	Acute Coronary Syndrome 01/2008 - 09/2003
3	Arteriosclerosis 10/2003 - 04/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2008 - 06/2006
2	Infection 01/2008 - 07/2002
2	Abdominal Aortic Aneurysm 11/2007 - 02/2006
2	Syndrome 09/2007 - 03/2006
2	Tissue Adhesions 08/2006 - 02/2006
2	Coronary Disease (Coronary Heart Disease) 11/2004 - 07/2004
1	Obesity 08/2008
1	Reperfusion Injury 03/2008
1	Myocardial Infarction 01/2008
1	Diabetes Mellitus 02/2007
1	Arteritis 02/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2004
1	Shock 09/2002

Drug/Important Bio-Agent (IBA)

6	CD40 Ligand (CD40L)IBA 03/2007 - 01/2003
5	LDL Receptors (LDL Receptor)IBA 04/2007 - 09/2002
4	atorvastatin (Lipitor)FDA Link 03/2008 - 09/2003
3	CytokinesIBA 06/2007 - 07/2002
3	C-Reactive ProteinIBA 04/2006 - 03/2004
2	Peroxidase (Myeloperoxidase)IBA 03/2008 - 11/2007
2	AdiponectinIBA 02/2008 - 03/2006
2	cathepsin LIBA 04/2007 - 02/2006
2	Lipoproteins (Lipoprotein)IBA 02/2007 - 02/2006
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2006 - 08/2006
2	Apolipoprotein C-IIIIBA 08/2006 - 02/2006
2	CholesterolIBA 07/2004 - 09/2002
1	Interferon-gamma (Interferon, gamma)IBA 08/2008
1	LigandsIBA 02/2008
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2008
1	Pancreatic Elastase (Elastase)IBA 11/2007
1	Interleukin-18 (Interleukin 18)IBA 09/2007
1	cathepsin K (cathepsin O)IBA 05/2007
1	PPAR alphaIBA 02/2007
1	PPAR gammaIBA 02/2007
1	Apolipoprotein B-100 (Apo B 100)IBA 01/2007
1	PhospholipidsIBA 01/2007
1	Biological Markers (Surrogate Marker)IBA 06/2006
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 04/2006
1	ApolipoproteinsIBA 02/2006
1	Leukotriene B4IBA 07/2005
1	Antihypertensive Agents (Antihypertensives)IBA 11/2004
1	Cysteine Endopeptidases (Cysteine Proteases)IBA 08/2004
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2004
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2004
1	AntigensIBA 04/2004
1	cathepsin SIBA 03/2003
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 07/2002
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2002
1	Interleukin-18 ReceptorsIBA 01/2002
1	InterleukinsIBA 01/2002

Therapy/Procedure

2	Homologous Transplantation (Allograft) 10/2003 - 03/2003
1	Therapeutics 04/2007
1	Transplantation (Transplant Recipients) 04/2002